The innate immune system in Alzheimer's disease
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the leading cause for dementia in the world. It is characterized by two biochemically distinct types of protein aggregates: amyloid β (A β ) peptide in the forms of parenchymal amyloid plaques and congophilic amyloid angiopathy (CAA) and aggregated tau protein in the form of intraneuronal neurofibrillary tangles (NFT). Several risk factors have been discovered that are associated with AD. The most well-known genetic risk factor for late-onset AD is apolipoprotein E4 (ApoE4) (Potter and Wisniewski (2012), and Verghese et al. (2011)). Recently, it has been reported by two groups independently that a rare functional variant (R47H) of TREM2 is associated with the late-onset risk of AD. TREM2 is expressed on myeloid cells including microglia, macrophages, and dendritic cells, as well as osteoclasts. Microglia are a major part of the innate immune system in the CNS and are also involved in stimulating adaptive immunity. Microglia express several Toll-like receptors (TLRs) and are the resident macrophages of the central nervous system (CNS). In this review, we will focus on the recent advances regarding the role of TREM2, as well as the effects of TLRs 4 and 9 on AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TREM2 suppresses inflammation by inhibiting the production and secretion of cytokines that are initiated by TLR2 and TLR4 signaling [29]”
From Microglial dysfunction in brain aging and Alzheimer's disease (2014) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304 · cited 1×
“TLR11, 12, and 1 that are not present in the human genome [50].”
BackgroundDefective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · cited 1×
“It recognizes microbial motifs of LPS (lipopolysaccharides) [62, 63].”
BackgroundA Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 4×
“TLR9 was originally identified as a receptor that could differentially recognize bacterial DNA versus mammalian DNA, based on the high frequency of hypomethylated CpG motifs in nonmammalian DNA [71, 72].”
BackgroundInfluentialTakeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590 · cited 2×
“Toll was first identified as a receptor expressed by insects and was found to be essential for establishing dorsal-ventral orientation during embryonic development in Drosophila melanogaster [42] and for being important for defense against microbial infection [43, 44].”
BackgroundLemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.-M., & Hoffmann, J. A. (1996) · Cell · doi:10.1016/s0092-8674(00)80172-5 · Cited by 4,043
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“Subsequently, this association was replicated in cohorts from the USA, Germany, The Netherlands, and Norway [9].”
ResultNelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · cited 1×
“NFT deposition correlates better with the degree of dementia, compared to the amyloid plaque burden [35].”
BackgroundKawai, T., & Akira, S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,810
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · cited 2×
“Fibrillar A𝛽 triggers microglia inflammatory cytokine production via TLR4-TLR6 heterodimers, whose assembly is regulated by CD36 [51].”
BackgroundCSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291 · cited 1×
“A number of studies have shown that increases of hyperphosphorylated tau protein (ptau) in CSF correlate with neuronal loss and is predictive of cognitive decline in AD [36–40].”
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284 · cited 2×
“Microglia can also play a neuroprotective role by clearing Aβ via increased phagocytosis and proteolytic degradation [53–55].”
BackgroundBouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284 · cited 2×
“[15] A.”
BackgroundTherapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246 · cited 1×
“Several CpG DNA drugs have demonstrated good safety profiles in humans and have been tested in numerous clinical trials as antitumor, antimicrobial agents, and adjuvants in vaccines [90, 91].”
BackgroundCrystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran
Kim, H. M., Park, B. S., Kim, J.-I., Kim, S. E., Lee, J., Oh, S. C., Enkhbayar, P., Matsushima, N., Lee, H., Yoo, O. J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.002 · Cited by 1,177 · cited 1×
“It recognizes microbial motifs of LPS (lipopolysaccharides) [62, 63].”
BackgroundHashimoto, C., Hudson, K. L., & Anderson, K. V. (1988) · Cell · doi:10.1016/0092-8674(88)90516-8 · Cited by 1,090 · cited 2×
“[42] C.”
BackgroundToll‐like Receptor and RIG‐1‐like Receptor Signaling
Kawai, T., & Akira, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.020 · Cited by 986
The interface between innate and adaptive immunity
Hoebe, K., Janssen, E., & Beutler, B. (2004) · Nature Immunology · doi:10.1038/ni1004-971 · Cited by 916 · cited 1×
“TLRs are critical for eliciting an innate immune response to invading pathogens and are also important for triggering the adaptive immune responses [58, 59].”
BackgroundApolipoprotein E in Alzheimer’s disease and other neurological disorders
Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857 · cited 1×
“The most well-known genetic risk factor for late-onset AD is apolipoprotein E4 (ApoE4) (Potter and Wisniewski (2012), and Verghese et al. (2011)).”
BackgroundThe Genetics of Alzheimer's Disease
Bertram, L., & Tanzi, R. E. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 760
TLR signaling tailors innate immune responses in human microglia and astrocytes
Jack, C. S., Arbour, N., Manusow, J., Montgrain, V., Blain, M., McCrea, E., Shapiro, A., & Antel, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4320 · Cited by 734 · cited 1×
“TLRs are important in AD, specifically those expressed on microglia (TLRs 1–9) [75, 76].”
BackgroundAhmad-Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · Cited by 717 · cited 1×
“TLR9 is expressed in the cytoplasm within the endoplasmic reticulum, as well as on other intracellular vesicles but not on the plasma membrane [73].”
BackgroundCutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688 · cited 3×
“It recognizes microbial motifs of LPS (lipopolysaccharides) [62, 63].”
BackgroundPaloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683 · cited 1×
“TREM2 is a phagocytic receptor of bacteria [11] and forms a receptor signaling complex with the TYRO protein tyrosine kinase binding protein (TYROBP, also called DAP12), that triggers phagocytosis and the release of reactive oxygen species [21].”
BackgroundThe Toll receptor family and microbial recognition
Medzhitov, R., & Janeway, Jr. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01845-x · Cited by 676
Toll-like receptors modulate adult hippocampal neurogenesis
Rolls, A., Shechter, R., London, A., Ziv, Y., Ronen, A., Levy, R., & Schwartz, M. (2007) · Nature Cell Biology · doi:10.1038/ncb1629 · Cited by 622
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591
Buerger, K., Ewers, M., Pirttila, T., Zinkowski, R., Alafuzoff, I., Teipel, S. J., DeBernardis, J., Kerkman, D., McCulloch, C., Soininen, H., et al. (2006) · Brain · doi:10.1093/brain/awl269 · Cited by 586 · cited 1×
“A recent large GWAS study has shown that the Trem2 R47H variant has a strong association with both elevated CSF tau and ptau levels [41].”
BackgroundRademakers, R., Baker, M., Nicholson, A. M., Rutherford, N. J., Finch, N., Soto-Ortolaza, A., Lash, J., Wider, C., Wojtas, A., DeJesus-Hernandez, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.1027 · Cited by 571 · cited 1×
“Neither the latter disorder nor PLOSL is associated with amyloid plaques or NFT pathology; however, there is increasedmicrogliosis alongwith neurodegeneration, highlighting the likely importance of the balance between microglial phagocytic and inflammatory pathways in AD.”
BackgroundBoonstra, A., Asselin-Paturel, C., Gilliet, M., Crain, C., Trinchieri, G., Liu, Y.-J., & O'Garra, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021908 · Cited by 551
Recognition of microbial infection by Toll-like receptors
Kopp, E., & Medzhitov, R. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00080-3 · Cited by 548 · cited 1×
“Each TLR has at least one known binding ligand and/or adaptors except TLR10 [48, 49].”
BackgroundRole of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease
Walter, S., Letiembre, M., Liu, Y., Heine, H., Penke, B., Hao, W., Bode, B., Manietta, N., Walter, J., Schulz-Schüffer, W., et al. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110455 · Cited by 543 · cited 2×
“In AD model TgCRND8 mice TREM2 mRNA was increased, correlating with the rise in A𝛽 levels [7].”
BackgroundRole of toll-like receptor signalling in A uptake and clearance
Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2006) · Brain · doi:10.1093/brain/awl249 · Cited by 493
Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential
Hanke, M. L., & Kielian, T. (2011) · Clinical Science · doi:10.1042/cs20110164 · Cited by 492 · cited 2×
“Other pattern recognition receptors which have been shown to play a critical part in macrophage/microglial function and have a role in AD-related pathology are the Toll-like receptors (TLRs) [12–14].”
BackgroundTLR-4 Signaling Promotes Tumor Growth and Paclitaxel Chemoresistance in Ovarian Cancer
Kelly, M. G., Alvero, A. B., Chen, R., Silasi, D.-A., Abrahams, V. M., Chan, S., Visintin, I., Rutherford, T., & Mor, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3948 · Cited by 488 · cited 1×
“TLR4 has been found expressed in many other cells including epithelial [66], endothelial cells [67], and cancer cells [68, 69].”
BackgroundA role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., & Seaman, W. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06042.x · Cited by 475 · cited 1×
“TREM2 interacts with endogenous ligands on neurons, leading to the direct removal of damaged cells [27].”
BackgroundLoss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
Paloneva, J., Kestilä, M., Wu, J., Salminen, A., Böhling, T., Ruotsalainen, V., Hakola, P., Bakker, A. B. H., Phillips, J. H., Pekkarinen, P., et al. (2000) · Nature Genetics · doi:10.1038/77153 · Cited by 460 · cited 1×
“Affected individuals have a progressive inflammatory neurodegenerative disorder with formation of multiple bone cysts.”
BackgroundBouchon, A., Hernández-Munain, C., Cella, M., & Colonna, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1111 · Cited by 460
Inflammation, microglia, and alzheimer's disease
Cameron, B., & Landreth, G. E. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.006 · Cited by 444 · cited 1×
“It has been reported that TLRs on the surface of microglia cells bind Aβ, which triggers downstream intracellular signaling cascades [78, 79].”
BackgroundHamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., & Lanier, L. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2051 · Cited by 440 · cited 1×
“Conversely reduction of TREM2 expression by either RNA interference or by targeted gene deletion amplified inflammatory cytokine responses by macrophages following stimulation of multiple different TLRs including TLR2, 4, and 9 [26].”
BackgroundHampel, H., Buerger, K., Zinkowski, R., Teipel, S. J., Goernitz, A., Andreasen, N., Sjoegren, M., DeBernardis, J., Kerkman, D., Ishiguro, K., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.95 · Cited by 434 · cited 1×
“A number of studies have shown that increases of hyperphosphorylated tau protein (ptau) in CSF correlate with neuronal loss and is predictive of cognitive decline in AD [36–40].”
Takahashi, K., Prinz, M., Stagi, M., Chechneva, O., & Neumann, H. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040124 · Cited by 414 · cited 1×
“In various models of multiple sclerosis increased microglial expression of TREM2 is associated with increased phagocytosis and a promotion of aM2-like activation state of microglia, which is thought to have protective effects [28, 29].”
BackgroundGWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
Cruchaga, C., Kauwe, J. S. K., Harari, O., Jin, S. C., Cai, Y., Karch, C. M., Benitez, B. A., Jeng, A. T., Skorupa, T., Carrell, D., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.026 · Cited by 383 · cited 1×
“A recent large GWAS study has shown that the Trem2 R47H variant has a strong association with both elevated CSF tau and ptau levels [41].”
BackgroundGuerreiro, R. J., Lohmann, E., Brás, J. M., Gibbs, J. R., Rohrer, J. D., Gurunlian, N., Dursun, B., Bilgic, B., Hanagasi, H., Gurvit, H., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.579 · Cited by 374
Microbial Lipopeptides Stimulate Dendritic Cell Maturation Via Toll-Like Receptor 2
Hertz, C. J., Kiertscher, S. M., Godowski, P. J., Bouis, D. A., Norgard, M. V., Roth, M. D., & Modlin, R. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2444 · Cited by 356
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide
Liu, Y., Walter, S., Stagi, M., Cherny, D., Letiembre, M., Schulz-Schaeffer, W., Heine, H., Penke, B., Neumann, H., & Fassbender, K. (2005) · Brain · doi:10.1093/brain/awh531 · Cited by 349 · cited 1×
“Immunoreactivity with CD14 was detected in some perivascular areas [80].”
BackgroundHe, W., Liu, Q., Wang, L., Chen, W., Li, N., & Cao, X. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.01.022 · Cited by 340 · cited 1×
“TLR4 has been found expressed in many other cells including epithelial [66], endothelial cells [67], and cancer cells [68, 69].”
BackgroundOpal, S. M., & Esmon, C. T. (2002) · Critical Care · doi:10.1186/cc1854 · Cited by 340 · cited 1×
“TLR4 is mostly expressed in lymphocytes, monocytes, macrophages, and splenocytes [64, 65].”
BackgroundEnhanced Toll-like receptor responses in the absence of signaling adaptor DAP12
Hamerman, J. A., Tchao, N. K., Lowell, C. A., & Lanier, L. L. (2005) · Nature Immunology · doi:10.1038/ni1204 · Cited by 318 · cited 2×
“Conversely reduction of TREM2 expression by either RNA interference or by targeted gene deletion amplified inflammatory cytokine responses by macrophages following stimulation of multiple different TLRs including TLR2, 4, and 9 [26].”
BackgroundThe LPS receptor (CD14) links innate immunity with Alzheimer's disease
Fassbender, K., Walter, S., Kühl, S., Landmann, R., Ishii, K., Bertsch, T., Stalder, A. K., Muehlhauser, F., Liu, Y., Ulmer, A. J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0364fje · Cited by 307
Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis
Piccio, L., Buonsanti, C., Mariani, M., Cella, M., Gilfillan, S., Cross, A. H., Colonna, M., & Panina‐Bordignon, P. (2007) · European Journal of Immunology · doi:10.1002/eji.200636837 · Cited by 284 · cited 1×
“In various models of multiple sclerosis increased microglial expression of TREM2 is associated with increased phagocytosis and a promotion of aM2-like activation state of microglia, which is thought to have protective effects [28, 29].”
BackgroundFrackowiak, J., Wisniewski, H. M., Wegiel, J., Merz, G. S., Iqbal, K., & Wang, K. C. (1992) · Acta Neuropathologica · doi:10.1007/bf00227813 · Cited by 276
Jin, J.-J., Kim, H.-D., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-23 · Cited by 275 · cited 1×
“In addition, TLR4-deficient mice displayed increased diffuse Aβ and fibrillar Aβ deposits compared with control mice [78], suggesting that TLR4 signaling is involved in Aβ clearance [83].”
BackgroundAkira, S. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-32636-7_1 · Cited by 256
Michaud, J.-P., Hallé, M., Lampron, A., Thériault, P., Préfontaine, P., Filali, M., Tribout-Jover, P., Lanteigne, A.-M., Jodoin, R., Cluff, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215165110 · Cited by 252 · cited 1×
“Furthermore, stimulation of microglial cells with TLR2-, TLR4-, or TLR9-specific agonists accelerates Aβ clearance both in vitro and in vivo [85].”
BackgroundTREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice
Frank, S., Burbach, G. J., Bonin, M., Walter, M., Streit, W., Bechmann, I., & Deller, T. (2008) · Glia · doi:10.1002/glia.20710 · Cited by 247 · cited 1×
“In AD animal models, it has been reported that TREM2 is upregulated in amyloid plaque-associated microglia, such as in aged APP23 mice [19], a result which was confirmed by another group [20].”
BackgroundTREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria
N'Diaye, E.-N., Branda, C. S., Branda, S. S., Nevarez, L., Colonna, M., Lowell, C., Hamerman, J. A., & Seaman, W. E. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200808080 · Cited by 239 · cited 2×
“TREM2 was initially identified as a phagocytic receptor of bacteria [11].”
BackgroundWisniewski, H. M., Wegiel, J., Wang, K. C., & Lach, B. (1992) · Acta Neuropathologica · doi:10.1007/bf00311383 · Cited by 221 · cited 2×
“Studies conducted in the early 1990s have suggested the potentially critical role of microglia for both the formation and clearance of amyloid lesions [93–95].”
BackgroundMRI and CSF studies in the early diagnosis of Alzheimer's disease
De Leon, M. J., DeSanti, S., Zinkowski, R., Mehta, P. D., Pratico, D., Segal, S., Clark, C., Kerkman, D., DeBernardis, J., Li, J., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01381.x · Cited by 218 · cited 1×
“A recent large GWAS study has shown that the Trem2 R47H variant has a strong association with both elevated CSF tau and ptau levels [41].”
BackgroundFunctions of Toll-like receptors: lessons from KO mice
Akira, S., & Takeda, K. (2004) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2004.04.002 · Cited by 179 · cited 2×
“To date, 11 members of TLR family have been identified in humans and 13 in mice, which trigger both innate and adaptive immune responses [45–47].”
BackgroundVariant TREM2 as Risk Factor for Alzheimer's Disease
Neumann, H., & Daly, M. J. (2013) · New England Journal of Medicine · doi:10.1056/nejme1213157 · Cited by 177
Toll-Like Receptors in Alzheimer's Disease
Landreth, G. E., & Reed-Geaghan, E. G. (2009) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-00549-7_8 · Cited by 176 · cited 2×
“Microglia can also play a neuroprotective role by clearing Aβ via increased phagocytosis and proteolytic degradation [53–55].”
BackgroundInnate immune receptor expression in normal brain aging
Letiembre, M., Hao, W., Liu, Y., Walter, S., Mihaljevic, I., Rivest, S., Hartmann, T., & Fassbender, K. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.01.004 · Cited by 175 · cited 2×
“TLRs expression was identified on glial cells in human postmortem AD [74].”
BackgroundIto, H., & Hamerman, J. A. (2012) · European Journal of Immunology · doi:10.1002/eji.201141679 · Cited by 173
Scholtzova, H., Kascsak, R. J., Bates, K. A., Boutajangout, A., Kerr, D. J., Meeker, H. C., Mehta, P. D., Spinner, D. S., & Wisniewski, T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5715-08.2009 · Cited by 166 · cited 1×
“without apparent toxicity and improved cognitive function [88].”
BackgroundSelf-citationSessa, G., Podini, P., Mariani, M., Meroni, A., Spreafico, R., Sinigaglia, F., Colonna, M., Panina, P., & Meldolesi, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03729.x · Cited by 165 · cited 1×
“TREM2 is known to have anti-inflammatory properties; it suppresses inflammatory responses by repression of cytokine production and secretion [23].”
BackgroundTLR-4 deficiency protects against focal cerebral ischemia and axotomy-induced neurodegeneration
Kilic, U., Kilic, E., Matter, C. M., Bassetti, C. L., & Hermann, D. M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.03.002 · Cited by 159 · cited 1×
“TLR4 deficiency has been shown to be protective against ischemic damage and enhance neuronal survival in stroke mouse models [70].”
BackgroundCpG DNA: A pathogenic factor in systemic lupus erythematosus?
Krieg, A. Μ. (1995) · Journal of Clinical Immunology · doi:10.1007/bf01541318 · Cited by 155 · cited 4×
“TLR9 was originally identified as a receptor that could differentially recognize bacterial DNA versus mammalian DNA, based on the high frequency of hypomethylated CpG motifs in nonmammalian DNA [71, 72].”
BackgroundInfluentialToll-like receptors: balancing host resistance with immune tolerance
Pasare, C., & Medzhitov, R. M. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.09.002 · Cited by 147 · cited 1×
“TLRs are critical for eliciting an innate immune response to invading pathogens and are also important for triggering the adaptive immune responses [58, 59].”
BackgroundDoi, Y., Mizuno, T., Maki, Y., Jin, S., Mizoguchi, H., Ikeyama, M., Doi, M., Michikawa, M., Takeuchi, H., & Suzumura, A. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090418 · Cited by 135
Melchior, B., Garcia, A. E., Hsiung, B.-K., Lo, K. M., Doose, J. M., Thrash, J. C., Stalder, A. K., Staufenbiel, M., Neumann, H., & Carson, M. J. (2010) · ASN Neuro · doi:10.1042/an20100010 · Cited by 134
Jiang, T., Yu, J., Zhu, X., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8424-8 · Cited by 131 · cited 1×
“Hence, it has been speculated that TREM2 has a protective role in AD pathogenesis; its anti-inflammatory properties could reduce inflammation-induced innocent bystander neuronal damage [8, 16, 17].”
BackgroundToll-like Receptor 4 Mediates Innate Immunity to Kaposi Sarcoma Herpesvirus
Lagos, D., Vart, R. J., Gratrix, F., Westrop, S. J., Emuss, V., Wong, P., Robey, R. C., Imami, N., Bower, M., Gotch, F. M., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.09.012 · Cited by 117 · cited 1×
“TLR4 has been found expressed in many other cells including epithelial [66], endothelial cells [67], and cancer cells [68, 69].”
BackgroundToll-like receptors are key players in neurodegeneration
Arroyo, D. S., Soria, J. A., Gaviglio, E. A., Rodriguez-Galan, M. C., & Iribarren, P. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.05.006 · Cited by 117 · cited 4×
“Numerous studies have shown that TLRs have a crucial role in immune surveillance and inflammatory responses in the central nervous system (CNS) [12].”
BackgroundInfluentialGenetics of Alzheimer’s Disease
Ridge, P. G., Ebbert, M. T. W., & Kauwe, J. S. K. (2013) · BioMed Research International · doi:10.1155/2013/254954 · Cited by 92 · cited 9×
“Concurrently, Guerreiro et al. confirmed the link between LOAD and the R47H variant by meta-analysis of three imputed data sets of genomewide association studies (EADI, GERAD and ANM) [7].”
BackgroundInfluentialFrank, S., Copanaki, E., Burbach, G. J., Müller, U. C., & Deller, T. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.01.075 · Cited by 86 · cited 1×
“Treatment of microglia with plaque material produces marked upregulation of TLR2, TLR4, TLR5, TLR7, and TLR9 mRNA [52].”
BackgroundApolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade
Potter, H., & Wisniewski, T. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/489428 · Cited by 81 · cited 2×
“The most well-known genetic risk factor for late-onset AD is apolipoprotein E4 (ApoE4) (Potter and Wisniewski (2012), and Verghese et al. (2011)).”
BackgroundExpression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia
Yu, L., Wang, L., Li, M., Zhong, J., Wang, Z., & Chen, S. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0825-1 · Cited by 80
Inflammation and neurodegeneration: the story ‘retolled’
Drouin‐Ouellet, J., & Cicchetti, F. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.07.002 · Cited by 79 · cited 2×
“[14] J.”
BackgroundInnate Immunity in Alzheimer’s Disease: A Complex Affair
Guillot-Sestier, M.-V., & Town, T. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050008 · Cited by 72 · cited 2×
“Microglia can also play a neuroprotective role by clearing Aβ via increased phagocytosis and proteolytic degradation [53–55].”
BackgroundIncreasing CSF phospho-tau levels during cognitive decline and progression to dementia
Andersson, C., Blennow, K., Almkvist, O., Andreasen, N., Engfeldt, P., Johansson, S., Lindau, M. P., & Eriksdotter, M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.027 · Cited by 70 · cited 1×
“A recent large GWAS study has shown that the Trem2 R47H variant has a strong association with both elevated CSF tau and ptau levels [41].”
BackgroundShi, H., Belbin, O., Medway, C., Brown, K., Kalsheker, N., Carrasquillo, M., Proitsi, P., Powell, J., Lovestone, S., Goate, A., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.014 · Cited by 57 · cited 1×
“This finding adds to prior data linking other genes that are associated with microglia function and a low increased risk of LOAD, such as CR1, CD33, and MS4A4A/MS4A6A [96].”
ResultToll-like receptor 2 signaling is a mediator of apoptosis in herpes simplex virus-infected microglia
Aravalli, R. N., Hu, S., & Lokensgard, J. R. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-11 · Cited by 55
Spinner, D. S., Kascsak, R. B., LaFauci, G., Meeker, H. C., Ye, X., Flory, M. J., Kim, J. I., Schuller-Levis, G. B., Levis, W. R., Wisniewski, T., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106665 · Cited by 54 · cited 1×
“We had previously shown that CpG stimulation is beneficial for the generation of an immune response to prion disease [89].”
BackgroundLeite‐de‐Moraes, M., Lisbonne, M., Arnould, A., Machavoine, F., Herbelin, A., Dy, M., & Schneider, E. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1839::aid-immu1839>3.0.co;2-y · Cited by 53
Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease
Golde, T. E., Streit, W. J., & Chakrabarty, P. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt178 · Cited by 38 · cited 1×
“Hence, it has been speculated that TREM2 has a protective role in AD pathogenesis; its anti-inflammatory properties could reduce inflammation-induced innocent bystander neuronal damage [8, 16, 17].”
BackgroundFenoglio, C., Galimberti, D., Piccio, L. M., Scalabrini, D., Panina‐Bordignon, P., Buonsanti, C., Venturelli, E., Lovati, C., Forloni, G., Mariani, C. B., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.10.029 · Cited by 29 · cited 1×
“Affected individuals have a progressive inflammatory neurodegenerative disorder with formation of multiple bone cysts.”
BackgroundThe role of microglia in amyloid fibril formation.
Wisniewski, H. M., & Wegiel, J. (1994) · PubMed · Cited by 20
TREM2 : a new risk factor for Alzheimer's disease
Singaraja, R. R. (2013) · Clinical Genetics · doi:10.1111/cge.12108 · Cited by 19 · cited 1×
“TREM-2 is defined as an innate immune receptor expressed on the cell surface of microglia, macrophages, osteoclasts, and immature dendritic cells [22].”
BackgroundSynthetic immunostimulatory oligonucleotides in experimental and clinical practice
Bodera, P., Stankiewicz, W., & Kocik, J. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70899-x · Cited by 14 · cited 1×
“Several CpG DNA drugs have demonstrated good safety profiles in humans and have been tested in numerous clinical trials as antitumor, antimicrobial agents, and adjuvants in vaccines [90, 91].”
BackgroundP2‐368: Innate immunity stimulation as a novel therapeutic approach in Alzheimer's disease
Scholtzova, H., Goñi, F., Pan, J., Sun, Y., Li, J., Mehta, P. D., & Wısnıewskı, T. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.1078 · Cited by 2 · cited 1×
“Recently, we have shown that TLR9 stimulation with CpG in 3xTg ADmice with both amyloid plaque and NFT pathology greatly reduces both of these pathologies in association with cognitive benefits [92].”
Background
Research works printed but not linked: 6
- 10.1001/jamaneurol.2013.579 · DOI · Paper page
- 10.1086/342259 · DOI · Paper page
- 10.1007/978-3-642-00549-7-8 · doi:10.1007/978-3-642-00549-7-8
- 2006, Current Topics in Microbiology and Immunology, 311, 1
- 1992, Acta Neuropathologica, 84, 225
- 1994, Neuropathology and Applied Neurobiology, 20, 192
Cited by
Clearance systems in the brain—implications for Alzheimer disease
Tarasoff-Conway, J. M., Carare, R. O., Osorio, R. S., Glodzik, L., Butler, T., Fieremans, E., Axel, L., Rusinek, H., Nicholson, C., Zlokovic, B. V., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.119 · Cited by 1,678
Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288
Microglial dysfunction in brain aging and Alzheimer's disease
Mosher, K. I., & Wyss-Coray, T. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.008 · Cited by 618
“Additionally, TREM2 suppresses inflammation by inhibiting the production and secretion of cytokines that are initiated by TLR2 and TLR4 signaling [29] (Fig.”
BackgroundInflammatory Response in the CNS: Friend or Foe?
Sochocka, M., Diniz, B. S., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0297-1 · Cited by 573
Amyloid-Beta: A Crucial Factor in Alzheimer's Disease
Sadigh-Eteghad, S., Sabermarouf, B., Majdi, A., Talebi, M., Farhoudi, M., & Mahmoudi, J. (2015) · Medical Principles and Practice · doi:10.1159/000369101 · Cited by 537
Metadata
- Authors
- Boutajangout, A., & Wisniewski, T.
- Affiliations
- King Abdulaziz University (SA)
- Department of Neurology, New York University School of Medicine, Alexandria East River Science Park, 450 East 29th Street, Room 802, New York City, NY 10016, USA
- Venue
- International Journal of Cell Biology
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-7
- ISSN
- 1687-8876 (ISSN-L)
- 1687-8884
- PMC
- PMC3809371
- OpenAlex
- W2013165248
- Cited by
- 69
- References
- 93
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 6 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 6 · 2015: 12 · 2014: 14
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Cell Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (NS073502, AG20245)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, innate immunity, TREM2, microglia, TLR4, TLR9, amyloid-beta, tau protein, neurofibrillary tangles, APOE ε4, myeloid cells, neuroinflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.